Elucid Bioimaging: A Noninvasive Diagnostic Predicts Infarction Risk in Patients with CAD

article image
ARTICLE SUMMARY:

Clinicians need better information in the form of noninvasive tests to determine which patients are at risk for an ischemic event, which should go to the cath lab for an invasive procedure, and which should be treated with which drugs. In providing information about vessel and plaque structure as well as plaque composition, vascuCAP from Elucid Bioimaging provides answers.

Medical practice for any disease always begins with the least invasive options, and when those don’t work, moves up the curve to more invasive choices. Thus, a cardiologist who sees a patient with coronary artery disease will order a stress EKG or refer the patient for an imaging study known as computed tomography angiography (CTA) to learn to what degree the patient suffers from ischemia upon exertion, and where there might be stenosis in the arteries.

×



This article is restricted to subscribers only.

Sign in to continue reading.

Questions?

We're here to help! Please contact us at: